psychemdicslogo.jpg
Psychemedics Corporation Announces 4th Quarter and Year-End Results
February 11, 2020 17:25 ET | Psychemedics Corporation
ACTON, Mass., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced fourth quarter and year-end financial results for the period ended December 31, 2019.  The...
psychemdicslogo.jpg
Psychemedics Announces Second Quarter Results and Declares 92nd Consecutive Quarterly Dividend
July 23, 2019 17:25 ET | Psychemedics Corporation
ACTON, Mass., July 23, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced second quarter financial results for the period ended June 30, 2019.  The Company also announced...
psychemdicslogo.jpg
Psychemedics Test for Fentanyl Detection Cleared by FDA
April 24, 2019 08:00 ET | Psychemedics Corporation
ACTON, Mass., April 24, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced the industry’s...